Literature DB >> 19151113

Asymptomatic pericardial effusion in patients with systemic lupus erythematosus.

T Sugiura1, Y Kumon, H Kataoka, Y Matsumura, H Takeuchi, Y L Doi.   

Abstract

To determine the frequency and clinical correlates of asymptomatic pericardial effusion (PE) in patients with systemic lupus erythematosus (SLE), echocardiography and electrocardiography were performed in 50 consecutive patients with SLE. Among 50 patients with SLE, 12 patients (24%) had PE and 17 patients (34%) had hypoalbuminaemia. Patients with PE had a significantly lower serum albumin (P < 0.001), higher incidence of proteinuria (P = 0.003), higher C-reactive protein (P = 0.036) and pulmonary artery systolic pressure (P = 0.011) and tended to have a higher incidence of PR-segment depression (P = 0.082) compared with those without PE. When four variables (PR-segment depression, C-reactive protein, serum albumin and pulmonary artery systolic pressure) were used in the multivariate analysis, serum albumin (P = 0.005, odds ratio = 0.016) and pulmonary artery systolic pressure (P = 0.010, odds ratio = 1.106) emerged as significant variables related to the occurrence of asymptomatic PE. Thus, an increase in hydrostatic pressure of the right heart cavities and a decrease in colloid osmotic pressure were important factors associated with the presence of asymptomatic PE in patients with SLE.

Entities:  

Mesh:

Year:  2009        PMID: 19151113     DOI: 10.1177/0961203308094763

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

1.  Pulmonary hypertension in polymyositis.

Authors:  Han Wang; Tao Liu; Ying-ying Cai; Lian Luo; Meng Wang; Mengmeng Yang; Lin Cai
Journal:  Clin Rheumatol       Date:  2015-10-14       Impact factor: 2.980

Review 2.  Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis.

Authors:  Junzhe Chen; Ying Tang; Mingsheng Zhu; Anping Xu
Journal:  Clin Rheumatol       Date:  2016-08-09       Impact factor: 2.980

3.  Myopericarditis and severe myocardial dysfunction as the initial manifestation of systemic lupus erythematosus.

Authors:  Joaquín S Peñataro; Ana De Mingo; Ana Del Río; José A Martínez; Magda Heras; Ander Regueiro
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

Review 4.  Management of cardiovascular disease in patients with systemic lupus erythematosus.

Authors:  Paramarjan Piranavan; Andras Perl
Journal:  Expert Opin Pharmacother       Date:  2020-06-08       Impact factor: 3.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.